Sign in to continue:

Friday, April 17th, 2026

SIM Acquisition Corp. I 8-K Report April 2026 – Extension Amendment Proposal, NASDAQ Listing, and Key Corporate Information





SIM Acquisition Corp. I – Detailed Investor Update

SIM Acquisition Corp. I Announces Postponement of Shareholders Meeting

Key Report Highlights

  • Extraordinary General Meeting Postponed: SIM Acquisition Corp. I (“the Company”) has announced the postponement of its extraordinary general meeting (initially scheduled for April 15, 2026), which was to be held in lieu of its annual general meeting.
  • Purpose of Meeting: The meeting was intended for shareholders to consider and vote on several crucial proposals, including the Extension Amendment Proposal and the Auditor Ratification Proposal.
  • SEC Filings and Proxy Statement: The Company has already filed a definitive proxy statement on Schedule 14A with the U.S. Securities and Exchange Commission (SEC). Proxy materials were mailed to shareholders on or about April 1, 2026, with March 25, 2026 as the record date.
  • Participants in Proxy Solicitation: Directors, executive officers, and other persons associated with the Company may be deemed participants in the proxy solicitation. Their interests and roles are detailed in the filed proxy statement.
  • No Offer or Solicitation: The Company explicitly states this communication does not constitute an offer to sell or solicit an offer to buy any securities.
  • Forward-Looking Statements: The Form 8-K contains forward-looking statements subject to various risks and uncertainties. Investors are cautioned that actual results may differ materially from those anticipated.
  • Emerging Growth Company: SIM Acquisition Corp. I is classified as an emerging growth company and has not elected to use the extended transition period for new or revised financial accounting standards.
  • NASDAQ Listing and Securities: The Company’s securities include:
    • Units: Each consisting of one Class A ordinary share and one-half of a redeemable warrant (Trading Symbol: SIMAU)
    • Class A ordinary shares, par value \$0.0001 per share (Trading Symbol: SIMA)
    • Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at \$11.50 per share (Trading Symbol: SIMAW)

    All are listed on the Nasdaq Stock Market LLC.

Important Shareholder Information

Potential Price Sensitivity:

  • The postponement of the extraordinary general meeting may delay key shareholder decisions regarding the Extension Amendment Proposal and Auditor Ratification Proposal. Such delays can create uncertainty, particularly for investors focused on the Company’s potential business combinations or extensions of its corporate life.
  • The Company’s status as an emerging growth company and its choice not to use the extended transition period for accounting standards may impact future financial disclosures and reporting, which could affect investor confidence.
  • Any changes in the timing or content of shareholder meetings, or in management’s forward-looking statements, could influence the market price of SIM Acquisition Corp. I’s securities.
  • Investors should carefully monitor further announcements, as changes in timing or proposals related to the meeting could be material to the Company’s future direction, including any potential business combination or SPAC transaction.

Additional Details for Investors

Shareholders and other interested parties are strongly advised to review the definitive proxy statement and any other documents filed with the SEC, as these contain important information about the Company and the proposals under consideration. Free copies of the proxy statement and other filings are available at www.sec.gov or by contacting SIM Acquisition Corp. I at their Miami office or New York address.

Forward-Looking Statements

The Company’s Form 8-K includes “forward-looking statements” as defined in Sections 27A and 21E of the Securities Act and Exchange Act, respectively. These statements are based on management’s beliefs and assumptions as of the date of the report. Actual results may differ due to risks listed in the Company’s filings, including the Proxy Statement and its annual and quarterly reports. The Company undertakes no obligation to update these statements except as required by law.

Disclaimer


This article is provided for informational purposes only and does not constitute investment advice or a solicitation to buy or sell any securities. Investors should consult the Company’s filings with the SEC and their own financial advisors before making investment decisions. The Company’s forward-looking statements are subject to change based on new information, and the Company is not obligated to update these statements. Please review all risk factors and disclosures before investing.




View SIM Acquisition Corp. I Historical chart here



LeonaBio, Inc. Adopts 2026 Equity Incentive Plan and Amends Certificate of Incorporation – SEC 8-K Filing March 2026

LeonaBio, Inc. Shareholder Meeting: Key Approvals and Potent...

Ingevity Reports 2025 Financial Results: Strong Cash Flow, Portfolio Actions, and 2026 Outlook Highlights

Ingevity Corporation (NGVT) Full Year and Q4 2025 Financial ...

Gossamer Bio 2025 Annual Report: Seralutinib PAH Clinical Development, FDA Path, and Regulatory Strategy Insights

Gossamer Bio, Inc. 2025 Annual Report: Key Highlights for In...